Autologous peripheral blood stem cell transplantation with tandem transfusion of stem cells in treating hematological malignant disease-A report of 4 cases
返回论文页
|更新时间:2024-01-17
|
Autologous peripheral blood stem cell transplantation with tandem transfusion of stem cells in treating hematological malignant disease-A report of 4 cases
Journal of Chongqing Medical UniversityIssue 2, Pages: 302-304(2005)
LOU Shifeng, et al. Autologous peripheral blood stem cell transplantation with tandem transfusion of stem cells in treating hematological malignant disease-A report of 4 cases. [J]. Journal of Chongqing Medical University (2):302-304(2005)
LOU Shifeng, et al. Autologous peripheral blood stem cell transplantation with tandem transfusion of stem cells in treating hematological malignant disease-A report of 4 cases. [J]. Journal of Chongqing Medical University (2):302-304(2005) DOI: 10.13406/j.cnki.cyxb.2005.02.040.
Autologous peripheral blood stem cell transplantation with tandem transfusion of stem cells in treating hematological malignant disease-A report of 4 cases
Objective:To observe the effect of autologous peripheral blood stem cells transplantation (APBSCT) on neutropenia and thrombocytopenia when tandem transfusion of stem cells is given.Methods:4 patients with hematological disease were mobilized with Cy+AraC+G-CSF before peripheral blood stem cells(PBSC) were collected.Peripheral blood stem cells transfusion were on 0 day and 3rd day after conditioning regimens.Results:The sufficient number of CD34+ cells could be collected.Neutropenia lasted 5-12days
while severe thrombocytopenia(BPC≤20×10 9/L)lasted only 3-4 days.Conclusion:APBSCT with tandem transfusion of stem cells result in shortening period of neutropenia and thrombocytopenia
less occurrence of neutropenic fever and severe bleeding